Japan's next-generation homegrown supercomputer, Fugaku NEXT, is being developed with a radically different strategy from its predecessors, abandoning the single-minded pursuit of the world's fastest calculation speed in favor of artificial intelligence capabilities expected to accelerate breakthroughs in fields ranging from drug development and batteries to disaster prevention and food production.
A safety alert is expected to be issued as early as May 21st over Tavneos, a drug used to treat vasculitis, after 20 patients who took the medication died from serious liver dysfunction, according to people familiar with the matter.
As aging underground infrastructure becomes an increasing concern across Japan, the city of Yokkaichi in Mie Prefecture has developed a digital underground map designed to improve the management of sewer, water, gas, and electrical systems.
A mysterious object floating softly through the air has captured widespread attention online, with researchers at Nagoya University developing an ultra-lightweight material that appears to behave like a real-life “flying carpet.”
Japan has approved the application of public health insurance to a regenerative medicine product using iPS cells to treat Parkinson’s disease, marking the world’s first practical use of iPS cell-based regenerative medicine.
A crack was found in the cover surrounding the high-pressure turbine at Kansai Electric Power’s Mihama Nuclear Power Plant No. 3 reactor in Mihama, Fukui Prefecture, following a steam leak that occurred last week, the utility said.
Japan has approved the domestic manufacture and sale of an MMR vaccine that protects against measles, mumps, and rubella with a single injection, paving the way for its use in children aged one and older.
A steam leak was detected early on May 8th at the Mihama Nuclear Power Plant's Unit 3 in Fukui Prefecture, prompting Kansai Electric Power to manually shut down the reactor.